Literature DB >> 21980251

The role of transglutaminases in the pathophysiology of prostate cancer.

R J Ablin1, W G Jiang.   

Abstract

Entities:  

Year:  2011        PMID： 21980251      PMCID： PMC3185901          DOI： 10.3747/co.v18i5.853

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  11 in total

Review 1.  Transglutaminases: crosslinking enzymes with pleiotropic functions.

Authors:  Laszlo Lorand; Robert M Graham
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Molecular and catalytic properties of transglutaminases.

Authors:  J E Folk; S I Chung
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1973

4.  A tissue type transglutaminase in human seminal plasma.

Authors:  T C Whyard; R J Ablin
Journal:  Am J Reprod Immunol       Date:  1997-12       Impact factor: 3.886

5.  The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.

Authors:  Wen G Jiang; Richard J Ablin; Howard G Kynaston; Malcolm D Mason
Journal:  Microvasc Res       Date:  2008-10-15       Impact factor: 3.514

6.  Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation.

Authors:  Luigi Maiuri; Alessandro Luciani; Ida Giardino; Valeria Raia; Valeria R Villella; Maria D'Apolito; Massimo Pettoello-Mantovani; Stefano Guido; Carolina Ciacci; Mariano Cimmino; Olivier N Cexus; Marco Londei; Sonia Quaratino
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

7.  Effect of human seminal plasma on the lytic activity of natural killer cells and presumptive identification of participant macromolecules.

Authors:  R J Ablin; J M Bartkus; J Polgár
Journal:  Am J Reprod Immunol       Date:  1990-09       Impact factor: 3.886

8.  Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.

Authors:  Gaynor Davies; Richard J Ablin; Malcolm D Mason; Wen G Jiang
Journal:  J Exp Ther Oncol       Date:  2007

9.  Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.

Authors:  Devanand Sarkar; Irina V Lebedeva; Zao-zhong Su; Eun-Sook Park; Lejuan Chatman; Nicollaq Vozhilla; Paul Dent; David T Curiel; Paul B Fisher
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

Authors:  Richard J Ablin; Howard G Kynaston; Malcolm D Mason; Wen G Jiang
Journal:  J Transl Med       Date:  2011-04-28       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.